Elite Diagnostic Limited (JMSE:ELITE)
1.300
-0.010 (-0.76%)
At close: Aug 14, 2026
Elite Diagnostic Ratios and Metrics
Market cap in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 459 | 428 | 534 | 548 | 781 | 1,251 | |
Market Cap Growth | -14.47% | -19.87% | -2.58% | -29.86% | -37.57% | 18.00% |
Enterprise Value | 1,012 | 672 | 853 | 967 | 1,250 | 1,463 |
Last Close Price | 1.30 | 1.21 | 1.50 | 1.54 | 2.20 | 3.50 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.44 | 13.57 | 16.66 | 20.94 | 58.50 | 25.71 |
PS Ratio | 0.53 | 0.49 | 0.63 | 0.67 | 1.03 | 2.00 |
PB Ratio | 0.80 | 0.74 | 0.98 | 1.07 | 1.61 | 2.61 |
P/TBV Ratio | 0.80 | 0.74 | 0.99 | 1.08 | 1.63 | 2.63 |
P/FCF Ratio | - | - | 3.18 | 5.94 | - | - |
P/OCF Ratio | 3.18 | 2.96 | 2.05 | 3.32 | 6.98 | 8.46 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 1.17 | 0.77 | 1.00 | 1.18 | 1.66 | 2.34 |
EV/EBITDA Ratio | 3.95 | 2.62 | 4.13 | 4.84 | 7.23 | 8.25 |
EV/EBIT Ratio | 13.13 | 8.71 | 11.95 | 10.01 | 19.32 | 17.74 |
EV/FCF Ratio | - | - | 5.08 | 10.47 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 1.18 | 1.18 | 0.87 | 0.89 | 1.12 | 0.84 |
Debt / EBITDA Ratio | 2.64 | 2.64 | 1.99 | 1.99 | 2.71 | 2.14 |
Debt / FCF Ratio | - | - | 2.81 | 4.93 | - | - |
Net Debt / Equity Ratio | 0.96 | 0.96 | 0.45 | 0.82 | 1.01 | 0.68 |
Net Debt / EBITDA Ratio | 2.15 | 2.15 | 1.20 | 2.09 | 2.83 | 1.84 |
Net Debt / FCF Ratio | -1.89 | -1.89 | 1.47 | 4.52 | -18.96 | -2.55 |
Asset Turnover | 0.71 | 0.71 | 0.79 | 0.76 | 0.75 | 0.77 |
Quick Ratio | 1.20 | 1.20 | 2.30 | 0.74 | 0.91 | 1.30 |
Current Ratio | 1.49 | 1.49 | 2.39 | 0.78 | 1.01 | 1.37 |
Return on Equity (ROE) | 5.64% | 5.64% | 6.08% | 5.25% | 2.77% | 10.35% |
Return on Assets (ROA) | 3.97% | 3.97% | 4.11% | 5.60% | 4.01% | 6.36% |
Return on Invested Capital (ROIC) | 7.54% | 7.63% | 7.21% | 9.04% | 7.25% | 11.69% |
Return on Capital Employed (ROCE) | 6.80% | 6.80% | 7.30% | 11.90% | 7.10% | 10.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 6.86% | 7.37% | 6.00% | 4.78% | 1.71% | 3.89% |
FCF Yield | -63.61% | -68.34% | 31.47% | 16.85% | -3.31% | -10.22% |
Dividend Yield | 0.77% | - | 0.67% | - | - | 0.57% |
Payout Ratio | 11.11% | - | - | - | 52.94% | 65.36% |
Buyback Yield / Dilution | 0.95% | 0.95% | - | - | - | - |
Total Shareholder Return | 1.72% | 0.95% | 0.67% | - | - | 0.57% |